3,4-Diaminopyridine safety in clinical practice: an observational, retrospective cohort study

3,4-Diaminopyridine in the Treatment of Lambert–Eaton Myasthenic Syndrome

Kathleen M. McEvoy, Anthony J. Windebank, Jasper R. Daube et al. · New England Journal of Medicine · 1989 · 306 citations

Medicine, Neurology, Pharmacotherapy +12

EDMUS, a European database for multiple sclerosis.

Christian Confavreux, D. A. S. Compston, O.R. Hommes et al. · Journal of Neurology Neurosurgery & Psychiatry · 1992 · 305 citations · Full text

Health Professions, Biomedical Informatics, Neurology +16

The acute oral toxicity, repellency, and hazard potential of 998 chemicals to one or more species of wild and domestic birds

Edward W. Schafer, W. A. Bowles, Jeffrey A Hurlbut · Archives of Environmental Contamination and Toxicology · 1983 · 290 citations

Veterinary Medicine, Toxicology, Veterinary Toxicology +16

Treatment of downbeat nystagmus with 3,4-diaminopyridine

Michael Strupp, Olaf G. Schüler, S. Krafczyk et al. · Neurology · 2003 · 244 citations

Medicine, Neurology, Pharmacology +15

Plasma exchange and immunosuppressive drug treatment in the Lambert‐Eaton myasthenic syndrome

John Newsom–Davis, N.M.F. Murray · Neurology · 1984 · 234 citations

Medicine, Pharmacotherapy, Electrodiagnostic Medicine +10